Balyasny Asset Management
FLXN

Balyasny Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Balyasny Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-474,518
Closed -$6.24M – 1769
2020
Q2 		$6.24M Buy
+474,518
New +$4.92M 0.07% 460
2020
Q1 		– Sell
-397,107
Closed -$8.22M – 1703
2019
Q4 		$8.22M Sell
397,107
-54,932
-12% -$926K 0.05% 482
2019
Q3 		$6.2M Buy
+452,039
New +$5.36M 0.05% 505
2019
Q1 		– Sell
-15,303
Closed -$173K – 1789
2018
Q4 		$173K Sell
15,303
-2,566
-14% -$40.2K ﹤0.01% 1309
2018
Q3 		$334K Sell
17,869
-22,131
-55% -$508K ﹤0.01% 1479
2018
Q2 		$1.03M Buy
+40,000
New +$1.04M 0.01% 1120
2018
Q1 		– Sell
-100,000
Closed -$2.5M – 2469
2017
Q4 		$2.5M Buy
+100,000
New +$2.45M 0.01% 1075

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return